Recruiting patients for rare disease clinical trials across geographically dispersed populations

Clinical trial sponsors struggle to find and enroll sufficient patient participants for rare disease studies, forcing them to conduct trials in distant countries like Australia and New Zealand where patient populations may be more accessible. Current recruitment methods are inefficient, time-consuming, and result in delayed trial timelines, increased costs, and difficulty achieving enrollment targets for conditions affecting small patient populations.